Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BI-4020 | 2664214-60-0 | 98.82% | 50 MG
SDP

Supplier:  Medchemexpress LLC HY12955050MG

Encompass_Preferred

BI-4020 is a fourth-generation, orally active, and non-covalent EGFR tyrosine kinase inhibitor. It exhibits high kinome selectivity and favorable DMPK properties. This compound is stable under recommended storage conditions.

  • Inhibits the triple mutant EGFR del19 T790M C797S variant (IC50=0.2 nM in BaF3 cell lines).
  • Inhibits the double mutant EGFR del19 T790M and primary mutant EGFR del19 (IC50=1 nM).
  • Shows activity against EGFR wt (IC50=190 nM).
  • For research use only by suitably qualified experienced scientists.

Catalog No. 50-003-42352


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.